ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹19,054 Cr | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr |
What is the latest Total Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹19,054 Cr |
| Mar2025 | ₹15,953 Cr |
| Mar2024 | ₹14,060 Cr |
| Mar2023 | ₹12,454 Cr |
| Mar2022 | ₹12,760 Cr |
How is Total Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹19,054 Cr | 19.44 | |
| Mar2025 | ₹15,953 Cr | 13.46 | |
| Mar2024 | ₹14,060 Cr | 12.89 | |
| Mar2023 | ₹12,454 Cr | -2.40 | |
| Mar2022 | ₹12,760 Cr | - | |
Compare Total Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,670.4 Cr | -0.6% | -1.1% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -0.6% |
-1.1% |
-6.5% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses